Mechanism of action of erbB tyrosine kinase inhibitors

2003 ◽  
pp. 137-145
Author(s):  
David W. Fry
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Mechanism Of Action ◽  
Kinase Inhibitors

scholarly journals Erratum: Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)

Leukemia ◽  
2014 ◽  
Vol 28 (2) ◽  
pp. 471-472 ◽  
Author(s):  
T Zhou ◽  
S Georgeon ◽  
R Moser ◽  
D J Moore ◽  
A Caflisch ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Mechanism Of Action ◽  
Kinase Inhibitors

scholarly journals Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)

Leukemia ◽  
2013 ◽  
Vol 28 (2) ◽  
pp. 404-407 ◽  
Author(s):  
T Zhou ◽  
S Georgeon ◽  
R Moser ◽  
D J Moore ◽  
A Caflisch ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Mechanism Of Action ◽  
Kinase Inhibitors

scholarly journals Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors

2020 ◽  
Vol 11 (6) ◽  
pp. 665-675
Author(s):  
Andrea Unzue ◽  
Claudia Jessen-Trefzer ◽  
Dimitrios Spiliotopoulos ◽  
Eugenio Gaudio ◽  
Chiara Tarantelli ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Mechanism Of Action ◽  
Tumor Size ◽  
Kinase Inhibitors ◽  
High Efficacy ◽  
Quinoxaline Derivatives

Two novel quinoxaline-based EphA3 tyrosine kinase inhibitors have been designed and characterized in vivo in a relevant lymphoma model, showing high efficacy in the control of tumor size.

Side effects of tyrosine kinase inhibitors (TKIs) on bone remodelling

2012 ◽  
Vol 224 (03) ◽  
Author(s):  
JT Tauer ◽  
A Ulmer ◽  
LC Hofbauer ◽  
M Suttorp
Keyword(s):  
Side Effects ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Bone Remodelling

A framework for risk stratification in EGFR+ lung adenocarcinoma treated with tyrosine kinase inhibitors

2019 ◽  
Author(s):  
P Christopoulos ◽  
M Kirchner ◽  
F Bozorgmehr ◽  
N Magios ◽  
AL Volckmar ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document